Jan Van de Winkel - President and Chief Executive Officer @ Genmab

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

90,190

Primary Job Title President and Chief Executive Officer
Primary Organization
Genmab

Location Utrecht, Utrecht, The Netherlands
Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
Gender Male

LinkedIn View on LinkedIn

Jan G. J. Van de Winkel is based out of Utrecht, Utrecht, and is the President and Chief Executive Officer of Genmab and also Board of Director of Novo Nordisk. Jan previously worked at Medarex as a Vice President, Medarex Europe.

Jobs

Number of Current Jobs

Number of Past Jobs

Jan Van de Winkel

is the

President and Chief Executive Officer

Genmab

. Additionally,

Jan Van de Winkel

has had

past job as the

Vice President, Medarex Europe

Medarex

Genmab President and Chief Executive OfficerJun 2010

Organization Name	Title At Company	Start Date	End Date
Medarex	Vice President, Medarex Europe	Jan 1998	Jun 2000

Board and Advisor Roles

Number of Current Board & Advisor Roles

Jan Van de Winkel

is the

Board of Director

Novo Nordisk

Novo Nordisk Board of DirectorFeb 2026

Related Hubs

Hub Name	CB Rank (Hub)
Europe Companies With More Than $1B in Revenue	2,208
Europe Public Companies With More Than $1B in Revenue	5,915
European Union (EU) Companies With More Than $1B in Revenue	4,532
European Union (EU) Public Companies With More Than 50 Employees	12,825
Europe Medical Companies (Top 10K)	2,556
Medical Companies With More Than $50M in Revenue	4,005
Europe Public Companies	8,657
Europe Public Companies With More Than $500 in Revenue	5,336
Biotechnology Public Companies With More Than 50 Employees	15,344
European Union (EU) Public Companies With More Than $1B in Revenue	11,654